Log-in / Create Account  
Session Information
2007 BIO International Convention
Click here to go to the previous page
Cutting Edge: Screening and Reengineering Biological Therapeutics
Track : Drug Discovery and Development
Program Code: DDD010
Date: Tuesday, May 8, 2007
Time: 9:15 AM to 10:45 AM  
Location: 259 AB
CHAIR :
Jens Eckstein, Partner and Kauffman Fellow, TVM Capital Corp.
SPEAKER (S):
David Zopf, MD, Executive Vice President & CSO, Neose Technologies, Inc.
Anne De Groot, President and CEO, EpiVax Inc.
Glenn Pierce, Vice President of Research, Biological Products Div., Bayer HealthCare LLC
Description
By many industry accounts, the therapeutic proteins market could reach $57 billion by 2010. The experienced academic and industry members of this panel will talk about the challenges in the development of protein therapeutics and describe new means of overcoming potential barriers to enter the clinic and achieve therapeutic success.



Objectives:
  • Discuss how to assessing and avoid immunogenicity in biologicals.

  • Describe engineering of novel scaffolds for biologicals.

  • Discuss improving biologicals with glycosylation technologies.

    • Streaming Audio with
    PowerPoint Slides
    (Code: DDD010)
      
    This session is a part of:
    Drug Discovery and Development 2-DAY TRACK
    Complete Set of BIO Online / CD-ROM - All 23 Tracks.